drugset / Trial / NCT00889473
Study of the Efficacy of Larazotide Acetate to Treat Celiac Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is designed to evaluate the efficacy of a single dose of larazotide acetate in preventing intestinal permeability changes induced by a 6-week gluten challenge in subjects with celiac disease
Timeline
- Start
- 2009-04
- Primary completion
- 2009-11
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Larazotide | Peptide | 1 mg | — |